Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02940899 · ClinicalTrials.gov registry record · NA

Syracuse University Fit Families Program: Autism

A NA study of Autism Spectrum Disorders, sponsored by Syracuse University.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT02940899: Completed NA study of Autism Spectrum Disorders, sponsored by Syracuse University.

NCT02940899 is a NA study of Autism Spectrum Disorders that has completed, run by Syracuse University. The registered enrollment target is 36 participants, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02940899, a NA study of Autism Spectrum Disorders, has completed, sponsored by Syracuse University.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

Syracuse University Fit Families is designed to increase the activity level and frequency of the children through modified activities using adapted equipment and, importantly, to increase the families' comfort level in having their children participate in a variety of physical activities, including team and individual sports.

Primary Outcome

To assess physical activity levels among families of children with autism spectrum disorders. This outcome will be measured by counting steps by day using accelerometry.

Conditions Studied

Interventions

  • OTHER Intervention: Syracuse University Fir Families Program (SUFFP)

Study Locations (1)

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2015-01
Est. Completion 2018-12-30
Phase NA
Syracuse University

31 total trials

What the finished NCT02940899 record still lists

NCT02940899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 166-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intervention: Syracuse University Fir Families Program (SUFFP) is the first listed.

NCT02940899 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02940899 about?

NCT02940899 is a clinical study titled "Syracuse University Fit Families Program: Autism". Syracuse University Fit Families is designed to increase the activity level and frequency of the children through modified activities using adapted equipment and, importantly, to increase the families' comfort level in having their children participate in a variety of physical activities, including ...

What is the current status of trial NCT02940899?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2015-01. Estimated completion is 2018-12-30.

What conditions does trial NCT02940899 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT02940899?

The interventions under investigation include: Intervention: Syracuse University Fir Families Program (SUFFP) (OTHER).

Who is sponsoring clinical trial NCT02940899?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02940899 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02940899's enrollment target sits among peer trials

36 13th of 20 higher than 8 of 20 other Autism Spectrum Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02940899, the US trial registry maintained by the National Library of Medicine. NCT02940899 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.